Vojislav Vukovic has joined Aileron Therapeutics (NASDAQ: [[ticker:ALRN]]) to serve as the Watertown, MA, company’s chief medical officer. He succeeds Manual Aivado, who was promoted to CEO in September. Vukovic was most recently chief medical officer of Taiho Oncology. Aileron is testing its lead drug candidate, ALRN-6924, in multiple clinical trials as a treatment for various cancers.
Author: Frank Vinluan
Xconomy Editor Frank Vinluan is a business journalist with experience covering technology and life sciences. Based in Raleigh, he was a staff writer at the Triangle Business Journal covering technology, biotechnology and energy before joining MedCityNews.com as North Carolina bureau chief. Prior to moving to North Carolina’s Research Triangle in 2007 he held business reporting positions at The Des Moines Register and The Seattle Times.
View all posts by Frank Vinluan
